サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1643503

心臓病学における人工知能の世界市場

Artificial Intelligence in Cardiology

出版日
ページ情報
英文 172 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
心臓病学における人工知能の世界市場
出版日: 2025年01月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 172 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓病学における人工知能の世界市場は2030年までに43億米ドルに達する見込み

2024年に13億米ドルと推定される心臓病学における人工知能の世界市場は、2024～2030年の分析期間においてCAGR 22.7%で成長し、2030年には43億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるCardiology AI Hardwareは、CAGR 22.3%を記録し、分析期間終了までに17億米ドルに達すると予測されます。心臓病学AIサービスセグメントの成長率は、分析期間でCAGR19.9％と推定されます。

米国市場は3億2,890万米ドルと推定、中国はCAGR21.6％で成長予測

米国の心臓病学における人工知能市場は、2024年に3億2,890万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに6億5,410万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは21.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ20.7%と19.6%と予測されています。欧州では、ドイツがCAGR約15.7%で成長すると予測されています。

世界の心臓病学における人工知能市場- 主要動向と促進要因まとめ

AIは心臓病診断と治療をどのように変革するか？

人工知能（AI）は、精密診断、予測分析、個別化治療戦略を可能にすることで、心臓病学に革命をもたらしています。心臓病学における従来の診断方法は、画像、心電図（ECG）、その他の臨床データの手動解釈に頼ることが多く、時間がかかり、ばらつきが生じやすいです。AIは、大規模なデータセットを圧倒的なスピードと正確さで分析することで、こうした課題に対処し、人間の医師が見過ごす可能性のあるパターンや異常を特定します。

例えば、AIを搭載した画像診断システムは、冠動脈疾患、不整脈、心不全などの診断精度を向上させる。機械学習アルゴリズムは心エコー図、CTスキャン、MRIを処理し、心臓の機能と構造に関する詳細な洞察を提供することで、より早く正確な診断を可能にします。さらに、AI主導の心電図解析システムは、不整脈やその他の電気的異常をリアルタイムで検出し、タイムリーな介入を保証することで転帰を改善します。

治療計画では、AIが遺伝学、病歴、ライフスタイルなど患者固有の要因を分析することで、個別化治療を可能にしています。予測モデルは心血管イベントのリスクを評価し、予防措置や治療計画を調整する際に医師を導く。このような進歩は、循環器科医療の質と効率の向上におけるAIの変革的役割を強調するものです。

心臓病学におけるAIの採用を推進するものは何か？

心血管疾患（CVDs）の世界の負担増は、循環器内科におけるAI導入の重要な促進要因です。CVDは依然として世界の死因のトップであり、予防、診断、治療を強化する革新的なソリューションが必要とされています。AIを搭載したツールは、高リスクの患者を早期に特定し、予防措置を実施する能力をヘルスケア専門家に提供し、これらの疾患の有病率と重症度を低下させます。

質の高い臨床データの入手可能性が高まっていることも、重要な要因のひとつです。ウェアラブルデバイス、遠隔モニタリングシステム、電子カルテなどのデータ収集技術の進歩により、膨大な量の心血管データが生成されます。AIシステムはこのデータを分析して実用的な知見を発見し、リアルタイムのモニタリングと意思決定を可能にします。このような機能は、専門的な心臓病治療へのアクセスが制限されているような、遠隔地や資源に制約のある環境では特に価値があります。

さらに、遠隔医療プラットフォームとAIの統合は、心臓病学サービスへのアクセスを強化しています。AI主導のツールは、患者データを分析し、医師に診断上の推奨事項を提供することで、遠隔診察をサポートします。この統合により、特に十分な医療が行き届いていない地域では、医療へのアクセス性と効率が向上しています。これらの動向は、現代の心臓病診療の重要な要素としてAIへの依存が高まっていることを浮き彫りにしています。

AIは患者の転帰を改善し、心血管治療を最適化できるか？

AIは患者の転帰を改善し、心血管治療の提供を最適化する上で極めて重要な役割を果たしています。より早く正確な診断を可能にすることで、AIは合併症のリスクを低減し、治療効果を高めます。予測分析ツールは、心臓発作や脳卒中などの疾患のリスクがある患者を特定し、ヘルスケアプロバイダーが予防措置を実施して死亡率を低減できるようにします。

外科手術やインターベンショナル・カーディオロジーでは、AIが計画と実行を支援しています。AIが誘導するロボット支援システムは、ステント留置や弁置換などの手技の精度を向上させ、リスクを最小限に抑え、回復の成果を向上させる。さらに、AI主導の臨床意思決定支援システムは、医師が最も適切な治療法を選択するのを支援し、個々の患者に最適な治療を保証します。

遠隔患者モニタリングにおけるAIの役割も、転帰の改善に貢献しています。AIアルゴリズムを搭載したウェアラブル端末は、心拍数や血圧などのバイタルサインを追跡し、悪化の早期警告サインを検出します。このリアルタイムのモニタリングにより、患者は自分の状態を効果的に管理できるようになり、医師は必要に応じて迅速に介入できるようになります。これらの進歩は、AIが心血管治療を変革し、世界中の何百万人もの患者の生活を改善する可能性を強調しています。

何が心臓病学分野のAI市場の成長を牽引しているのか？

心臓病学における人工知能市場の成長は、心血管の健康課題への対処における変革の可能性を反映した、いくつかの重要な要因によって牽引されています。心血管疾患の有病率の増加と、それに伴う高度な診断・治療ソリューションの需要は、重要な成長促進要因です。AIを搭載したツールは、循環器科ワークフローの精度と効率を高め、質の高いケアに対するニーズの高まりに対応します。

AIアルゴリズムの技術的進歩は、ウェアラブルデバイスや遠隔モニタリングシステムの普及と相まって、この分野における継続的なイノベーションを可能にしています。これらのツールはリアルタイムのデータを生成し、それをAIシステムが分析することで、実用的な洞察とパーソナライズされたケアの推奨を提供します。AI駆動型医療機器に対する規制当局の支援とヘルスケア技術への投資の拡大が、市場の拡大をさらに後押ししています。

利用しやすく効率的なヘルスケアに対する消費者の期待も、心臓病学におけるAIの採用に寄与しています。患者は先を見越した健康管理を可能にするツールを求めるようになっており、AIソリューションは予測分析や遠隔モニタリング機能を提供することでこの需要に対応しています。これらの要因は、継続的な研究開発と相まって、心臓病学におけるAI市場の急成長を後押ししており、心臓血管ケアにおける将来の進歩の要として位置付けられています。

セグメント

コンポーネント（ハードウェア・コンポーネント、サービス・コンポーネント、ソフトウェア・コンポーネント）、病状（虚血性心疾患／CAD病状、心不整脈病状、心不全病状、その他の病状）、アプリケーション（診断アプリケーション、創薬アプリケーション、予測アプリケーション、その他のアプリケーション）

調査対象企業の例（全36件）

  • CardiAI, Inc.
  • Cleerly, Inc.
  • IDOVEN
  • Koninklijke Philips NV
  • RSIP Vision
  • Tempus AI, Inc.
  • UltraSight
  • Ultromics Limited
  • Vista.ai
  • Viz

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29253

Global Artificial Intelligence in Cardiology Market to Reach US$4.3 Billion by 2030

The global market for Artificial Intelligence in Cardiology estimated at US$1.3 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 22.7% over the analysis period 2024-2030. Cardiology AI Hardware, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Cardiology AI Services segment is estimated at 19.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$328.9 Million While China is Forecast to Grow at 21.6% CAGR

The Artificial Intelligence in Cardiology market in the U.S. is estimated at US$328.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$654.1 Million by the year 2030 trailing a CAGR of 21.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.7% and 19.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.7% CAGR.

Global Artificial Intelligence in Cardiology Market - Key Trends & Drivers Summarized

How Is AI Transforming Cardiology Diagnostics and Treatment?

Artificial Intelligence (AI) is revolutionizing cardiology by enabling precise diagnostics, predictive analytics, and personalized treatment strategies. Traditional diagnostic methods in cardiology often rely on manual interpretation of imaging, electrocardiograms (ECGs), and other clinical data, which can be time-consuming and prone to variability. AI addresses these challenges by analyzing large datasets with unparalleled speed and accuracy, identifying patterns and abnormalities that might be overlooked by human practitioners.

For example, AI-powered imaging systems enhance the accuracy of diagnosing conditions such as coronary artery disease, arrhythmias, and heart failure. Machine learning algorithms process echocardiograms, CT scans, and MRIs to deliver detailed insights into cardiac function and structure, enabling earlier and more accurate diagnosis. Additionally, AI-driven ECG analysis systems detect arrhythmias and other electrical anomalies in real time, improving outcomes by ensuring timely intervention.

In treatment planning, AI is enabling personalized care by analyzing patient-specific factors such as genetics, medical history, and lifestyle. Predictive models assess the risk of cardiovascular events, guiding physicians in tailoring preventive measures and treatment plans. These advancements underscore AI’s transformative role in improving the quality and efficiency of cardiology care.

What Drives the Adoption of AI in Cardiology?

The rising global burden of cardiovascular diseases (CVDs) is a significant driver of AI adoption in cardiology. CVDs remain the leading cause of death worldwide, necessitating innovative solutions to enhance prevention, diagnosis, and treatment. AI-powered tools provide healthcare professionals with the ability to identify high-risk patients early and implement preventive measures, reducing the prevalence and severity of these conditions.

The increasing availability of high-quality clinical data is another critical factor. Advances in data collection technologies, such as wearable devices, remote monitoring systems, and electronic health records, generate vast amounts of cardiovascular data. AI systems analyze this data to uncover actionable insights, enabling real-time monitoring and decision-making. These capabilities are particularly valuable in remote and resource-constrained settings, where access to specialized cardiology care may be limited.

Moreover, the integration of AI with telemedicine platforms is enhancing access to cardiology services. AI-driven tools support remote consultations by analyzing patient data and providing physicians with diagnostic recommendations. This integration is improving care accessibility and efficiency, especially in underserved regions. These trends highlight the growing reliance on AI as a critical component of modern cardiology practice.

Can AI Improve Patient Outcomes and Optimize Cardiovascular Care?

AI is playing a pivotal role in improving patient outcomes and optimizing the delivery of cardiovascular care. By enabling earlier and more accurate diagnosis, AI reduces the risk of complications and enhances the effectiveness of treatments. Predictive analytics tools identify patients at risk of conditions such as heart attacks and strokes, allowing healthcare providers to implement preventive measures and reduce mortality rates.

In surgical and interventional cardiology, AI is assisting in planning and execution. Robotic-assisted systems guided by AI improve the precision of procedures such as stent placement and valve replacement, minimizing risks and improving recovery outcomes. Additionally, AI-driven clinical decision support systems aid physicians in selecting the most appropriate therapies, ensuring optimal care for individual patients.

AI’s role in remote patient monitoring is also contributing to better outcomes. Wearable devices equipped with AI algorithms track vital signs such as heart rate and blood pressure, detecting early warning signs of deterioration. This real-time monitoring empowers patients to manage their conditions effectively while enabling physicians to intervene promptly when necessary. These advancements underscore AI’s potential to transform cardiovascular care and improve the lives of millions of patients worldwide.

What’s Driving the Growth of the AI in Cardiology Market?

The growth in the Artificial Intelligence in Cardiology market is driven by several key factors, reflecting its transformative potential in addressing cardiovascular health challenges. The increasing prevalence of cardiovascular diseases and the associated demand for advanced diagnostic and therapeutic solutions are significant growth drivers. AI-powered tools enhance the accuracy and efficiency of cardiology workflows, meeting the growing need for high-quality care.

Technological advancements in AI algorithms, coupled with the proliferation of wearable devices and remote monitoring systems, are enabling continuous innovation in the field. These tools generate real-time data, which AI systems analyze to deliver actionable insights and personalized care recommendations. Regulatory support for AI-driven medical devices and growing investments in healthcare technology are further fueling market expansion.

Consumer expectations for accessible and efficient healthcare are also contributing to the adoption of AI in cardiology. Patients are increasingly seeking tools that enable proactive health management, and AI solutions address this demand by offering predictive analytics and remote monitoring capabilities. These factors, combined with ongoing research and development, are propelling the rapid growth of the AI in Cardiology market, positioning it as a cornerstone of future advancements in cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Cardiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Services Component, Software Component); Medical Condition (Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition, Other Medical Conditions); Application (Diagnosis Application, Drug Discovery Application, Prediction Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • CardiAI, Inc.
  • Cleerly, Inc.
  • IDOVEN
  • Koninklijke Philips NV
  • RSIP Vision
  • Tempus AI, Inc.
  • UltraSight
  • Ultromics Limited
  • Vista.ai
  • Viz

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Cardiology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI-Driven Cardiac Imaging Solutions Propel Growth in Early Diagnosis of Heart Conditions
    • Predictive Analytics in AI Strengthens Market for Risk Assessment in Cardiology
    • AI-Powered Wearable Devices Expand Opportunities in Remote Cardiac Monitoring
    • Advancements in AI-Enhanced ECG Analysis Drive Adoption in Diagnostic Centers
    • AI Algorithms for Detecting Heart Irregularities Strengthen Case for Faster Interventions
    • Integration of AI in Telecardiology Sets the Stage for Remote Healthcare Solutions
    • Demand for AI in Cardiac Rehabilitation Programs Spurs Adoption in Post-Care
    • AI Integration in Robotics for Cardiac Surgery Drives Demand in Minimally Invasive Techniques
    • Real-Time AI Insights for Blood Pressure Monitoring Propel Consumer Device Markets
    • AI in Remote Pacemaker Monitoring Highlights Consumer Health Potential
    • AI-Enhanced Cardiology Workflow Automation Drives Efficiency Across Hospitals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Cardiology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Prediction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Prediction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Drug Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Drug Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Ischemic Heart Disease / CAD Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Ischemic Heart Disease / CAD Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiac Arrhythmias Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cardiac Arrhythmias Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Heart Failure Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Heart Failure Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Medical Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Medical Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

IV. COMPETITION